(2026). Metabolic profile dynamics and cardiovascular risk markers in normal- and overweight women of reproductive age taking a monophasic combined oral contraceptive containing estetrol 15 mg and drospirenone 3 mg: An open-label observational study. Gynecology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Metabolic Profile Dynamics and Cardiovascular Risk Markers in Normal- and Overweight Women of Reproductive Age Taking a Monophasic Combined Oral Contraceptive Containing Estetrol 15 Mg and Drospirenone 3 Mg: An Open-label Observational Study."
Gynecology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Metabolic Profile Dynamics and Cardiovascular Risk Markers in Normal- and Overweight Women of Reproductive Age Taking a Monophasic Combined Oral Contraceptive Containing Estetrol 15 Mg and Drospirenone 3 Mg: An Open-label Observational Study."
Gynecology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.